Skip to content

Dr. Jill Devriese: value indication

Roughly what is an SME worth on what it filed? A range from its adjusted equity and its earnings, with your own assumptions, recalculated as you go.

Value indication

Dr. Jill Devriese

BE 0802.948.677
NACE 86.220, Specialist medical practice
latest balance sheet 30-06-2025indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€157,352 to €206,212

Midpoint €177,710 · 50% capitalised earnings, 50% adjusted equity

Adjusted equity €70,403
Capitalised earnings €244,300 to €342,020
Indication €157,352 to €206,212

Your assumptions

Capitalised earnings
%

The return a buyer expects on the money put in. Higher for more risk. The range also computes with 2 points more and less.

Adjust the equity
Blend
50%
Optional: your own multiple

Checked holds no market prices, so it suggests no multiple. If you have one from a transaction or a study, the tool applies it to the filed EBITDA less the net financial debt.

Adjusted equity

balance sheet 30-06-2025
Equity (10/15)
€70,403
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€70,403

Capitalised earnings

net result for the year (9904)
2025
€27,693
2024
€40,710
2023
-
Average result
€34,202
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€244,300 / €285,017 / €342,020

What this indication leaves out

  • Market prices and comparable transactions: Checked does not hold them.
  • Anything after the latest accounts, and items off the balance sheet (guarantees, leases, disputes).
  • The real value of buildings, stock and receivables: enter your own revaluation or adjustment.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale.

For a valuation to decide on: a company auditor or a certified accountant.

Source: filed annual accounts (NBB), latest balance sheet at 30 June 2025. Prepared on 29 September 2026 via checked.be. Indication, not a valuation or advice.